nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGS2—skin cancer	0.191	1	CbGaD
Indomethacin—ABCC6—Dactinomycin—skin cancer	0.132	0.239	CbGbCtD
Indomethacin—ABCC1—Vemurafenib—skin cancer	0.0588	0.106	CbGbCtD
Indomethacin—ABCC3—Fluorouracil—skin cancer	0.043	0.0777	CbGbCtD
Indomethacin—ABCC1—Dactinomycin—skin cancer	0.0391	0.0706	CbGbCtD
Indomethacin—ALB—Vismodegib—skin cancer	0.0343	0.062	CbGbCtD
Indomethacin—SLC22A7—Fluorouracil—skin cancer	0.0337	0.0608	CbGbCtD
Indomethacin—ABCC4—Fluorouracil—skin cancer	0.0329	0.0594	CbGbCtD
Indomethacin—ALB—Vemurafenib—skin cancer	0.0271	0.049	CbGbCtD
Indomethacin—SLC22A7—Docetaxel—skin cancer	0.0257	0.0464	CbGbCtD
Indomethacin—CYP2C19—Vismodegib—skin cancer	0.0223	0.0402	CbGbCtD
Indomethacin—ABCC1—Docetaxel—skin cancer	0.0202	0.0364	CbGbCtD
Indomethacin—CYP2C9—Vismodegib—skin cancer	0.0185	0.0334	CbGbCtD
Indomethacin—ABCB1—Vismodegib—skin cancer	0.018	0.0324	CbGbCtD
Indomethacin—ABCC2—Docetaxel—skin cancer	0.0149	0.027	CbGbCtD
Indomethacin—ALB—Fluorouracil—skin cancer	0.0122	0.022	CbGbCtD
Indomethacin—ABCB1—Dactinomycin—skin cancer	0.00943	0.017	CbGbCtD
Indomethacin—CYP2C9—Fluorouracil—skin cancer	0.00657	0.0119	CbGbCtD
Indomethacin—ABCC6—dermis—skin cancer	0.00632	0.0817	CbGeAlD
Indomethacin—ABCB1—Docetaxel—skin cancer	0.00487	0.00879	CbGbCtD
Indomethacin—PPARG—dermis—skin cancer	0.00328	0.0424	CbGeAlD
Indomethacin—PTGR2—nipple—skin cancer	0.00226	0.0293	CbGeAlD
Indomethacin—PPARG—leg—skin cancer	0.00216	0.028	CbGeAlD
Indomethacin—PPARG—forelimb—skin cancer	0.00215	0.0278	CbGeAlD
Indomethacin—GLO1—hair follicle—skin cancer	0.00206	0.0267	CbGeAlD
Indomethacin—PPARG—hindlimb—skin cancer	0.00193	0.025	CbGeAlD
Indomethacin—PTGDR2—female reproductive system—skin cancer	0.0017	0.022	CbGeAlD
Indomethacin—PPARA—blood vessel—skin cancer	0.00168	0.0217	CbGeAlD
Indomethacin—PPARG—appendage—skin cancer	0.00166	0.0214	CbGeAlD
Indomethacin—GLO1—nipple—skin cancer	0.0014	0.0181	CbGeAlD
Indomethacin—PLA2G2A—nipple—skin cancer	0.0013	0.0168	CbGeAlD
Indomethacin—CXCL8—nipple—skin cancer	0.00129	0.0166	CbGeAlD
Indomethacin—PPARA—neck—skin cancer	0.0012	0.0155	CbGeAlD
Indomethacin—ABCC11—female reproductive system—skin cancer	0.00112	0.0145	CbGeAlD
Indomethacin—PTGS2—leg—skin cancer	0.00111	0.0143	CbGeAlD
Indomethacin—AKR1C3—nipple—skin cancer	0.00101	0.013	CbGeAlD
Indomethacin—PPARG—endothelium—skin cancer	0.001	0.0129	CbGeAlD
Indomethacin—PTGS2—hindlimb—skin cancer	0.000987	0.0128	CbGeAlD
Indomethacin—PTGR2—head—skin cancer	0.000945	0.0122	CbGeAlD
Indomethacin—GLO1—epithelium—skin cancer	0.00094	0.0122	CbGeAlD
Indomethacin—PPARG—blood vessel—skin cancer	0.000923	0.0119	CbGeAlD
Indomethacin—PLA2G2A—connective tissue—skin cancer	0.000921	0.0119	CbGeAlD
Indomethacin—ABCC6—connective tissue—skin cancer	0.000912	0.0118	CbGeAlD
Indomethacin—GLO1—skin of body—skin cancer	0.000894	0.0116	CbGeAlD
Indomethacin—CES1—neck—skin cancer	0.000891	0.0115	CbGeAlD
Indomethacin—PLA2G2A—epithelium—skin cancer	0.000874	0.0113	CbGeAlD
Indomethacin—PPARA—connective tissue—skin cancer	0.00086	0.0111	CbGeAlD
Indomethacin—PTGS2—appendage—skin cancer	0.000847	0.011	CbGeAlD
Indomethacin—Bromfenac—PTGS2—skin cancer	0.000819	0.459	CrCbGaD
Indomethacin—PPARA—epithelium—skin cancer	0.000817	0.0106	CbGeAlD
Indomethacin—GLO1—mammalian vulva—skin cancer	0.000816	0.0106	CbGeAlD
Indomethacin—PPARA—skin of body—skin cancer	0.000777	0.0101	CbGeAlD
Indomethacin—ABCC1—hair follicle—skin cancer	0.000762	0.00986	CbGeAlD
Indomethacin—PLA2G2A—mammalian vulva—skin cancer	0.000758	0.00981	CbGeAlD
Indomethacin—GLO1—lymphoid tissue—skin cancer	0.000724	0.00937	CbGeAlD
Indomethacin—PTGS2—skin epidermis—skin cancer	0.000704	0.00912	CbGeAlD
Indomethacin—GLO1—female reproductive system—skin cancer	0.000699	0.00904	CbGeAlD
Indomethacin—PLA2G2A—lymphoid tissue—skin cancer	0.000673	0.00871	CbGeAlD
Indomethacin—PPARG—nipple—skin cancer	0.000667	0.00863	CbGeAlD
Indomethacin—PTGR2—lymph node—skin cancer	0.000661	0.00856	CbGeAlD
Indomethacin—PPARG—neck—skin cancer	0.00066	0.00854	CbGeAlD
Indomethacin—PLA2G2A—female reproductive system—skin cancer	0.000649	0.0084	CbGeAlD
Indomethacin—CES1—connective tissue—skin cancer	0.000638	0.00826	CbGeAlD
Indomethacin—PPARA—lymphoid tissue—skin cancer	0.000629	0.00814	CbGeAlD
Indomethacin—PPARA—female reproductive system—skin cancer	0.000607	0.00785	CbGeAlD
Indomethacin—AKR1C3—mammalian vulva—skin cancer	0.000589	0.00762	CbGeAlD
Indomethacin—GLO1—head—skin cancer	0.000584	0.00755	CbGeAlD
Indomethacin—SLC10A1—female reproductive system—skin cancer	0.000583	0.00755	CbGeAlD
Indomethacin—Tolmetin—PTGS2—skin cancer	0.000551	0.309	CrCbGaD
Indomethacin—UGT2B7—female reproductive system—skin cancer	0.000547	0.00707	CbGeAlD
Indomethacin—PLA2G2A—head—skin cancer	0.000543	0.00702	CbGeAlD
Indomethacin—ABCC6—head—skin cancer	0.000537	0.00695	CbGeAlD
Indomethacin—PTGS1—endothelium—skin cancer	0.000535	0.00692	CbGeAlD
Indomethacin—SLC22A11—female reproductive system—skin cancer	0.000533	0.00689	CbGeAlD
Indomethacin—ABCC1—nipple—skin cancer	0.000516	0.00668	CbGeAlD
Indomethacin—PTGS2—endothelium—skin cancer	0.000511	0.00661	CbGeAlD
Indomethacin—PPARA—head—skin cancer	0.000507	0.00656	CbGeAlD
Indomethacin—PTGS1—blood vessel—skin cancer	0.000493	0.00638	CbGeAlD
Indomethacin—SLC10A1—head—skin cancer	0.000487	0.00631	CbGeAlD
Indomethacin—PPARG—connective tissue—skin cancer	0.000473	0.00612	CbGeAlD
Indomethacin—PTGS2—blood vessel—skin cancer	0.000471	0.0061	CbGeAlD
Indomethacin—CES1—lymphoid tissue—skin cancer	0.000467	0.00604	CbGeAlD
Indomethacin—CES1—female reproductive system—skin cancer	0.00045	0.00583	CbGeAlD
Indomethacin—PPARG—epithelium—skin cancer	0.000449	0.00581	CbGeAlD
Indomethacin—PPARG—skin of body—skin cancer	0.000427	0.00553	CbGeAlD
Indomethacin—Naproxen—PTGS2—skin cancer	0.000414	0.232	CrCbGaD
Indomethacin—GLO1—lymph node—skin cancer	0.000409	0.00529	CbGeAlD
Indomethacin—PPARG—mammalian vulva—skin cancer	0.00039	0.00504	CbGeAlD
Indomethacin—SLCO1B1—female reproductive system—skin cancer	0.000387	0.005	CbGeAlD
Indomethacin—PLA2G2A—lymph node—skin cancer	0.00038	0.00492	CbGeAlD
Indomethacin—CXCL8—lymph node—skin cancer	0.000376	0.00487	CbGeAlD
Indomethacin—CES1—head—skin cancer	0.000376	0.00487	CbGeAlD
Indomethacin—ABCC3—female reproductive system—skin cancer	0.000367	0.00475	CbGeAlD
Indomethacin—PTGS1—nipple—skin cancer	0.000357	0.00461	CbGeAlD
Indomethacin—PPARA—lymph node—skin cancer	0.000355	0.00459	CbGeAlD
Indomethacin—PPARG—lymphoid tissue—skin cancer	0.000346	0.00448	CbGeAlD
Indomethacin—PPARG—female reproductive system—skin cancer	0.000334	0.00432	CbGeAlD
Indomethacin—ABCC3—head—skin cancer	0.000307	0.00397	CbGeAlD
Indomethacin—ABCC4—female reproductive system—skin cancer	0.000303	0.00392	CbGeAlD
Indomethacin—ABCC1—mammalian vulva—skin cancer	0.000302	0.0039	CbGeAlD
Indomethacin—AKR1C3—lymph node—skin cancer	0.000295	0.00382	CbGeAlD
Indomethacin—ABCC2—female reproductive system—skin cancer	0.000293	0.00379	CbGeAlD
Indomethacin—ABCB1—blood vessel—skin cancer	0.000292	0.00377	CbGeAlD
Indomethacin—PPARG—head—skin cancer	0.000279	0.00361	CbGeAlD
Indomethacin—CES1—lymph node—skin cancer	0.000263	0.00341	CbGeAlD
Indomethacin—SLCO1A2—head—skin cancer	0.000263	0.0034	CbGeAlD
Indomethacin—ABCC4—head—skin cancer	0.000253	0.00327	CbGeAlD
Indomethacin—PTGS1—connective tissue—skin cancer	0.000253	0.00327	CbGeAlD
Indomethacin—Thrombophlebitis—Docetaxel—skin cancer	0.000252	0.00201	CcSEcCtD
Indomethacin—SLC22A8—head—skin cancer	0.000251	0.00325	CbGeAlD
Indomethacin—Hepatitis—Dactinomycin—skin cancer	0.000251	0.002	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00025	0.002	CcSEcCtD
Indomethacin—Flushing—Bleomycin—skin cancer	0.000249	0.00199	CcSEcCtD
Indomethacin—Body temperature increased—Vemurafenib—skin cancer	0.000249	0.00199	CcSEcCtD
Indomethacin—Pancytopenia—Fluorouracil—skin cancer	0.000248	0.00198	CcSEcCtD
Indomethacin—Neuropathy peripheral—Temozolomide—skin cancer	0.000248	0.00198	CcSEcCtD
Indomethacin—Stomatitis—Temozolomide—skin cancer	0.000246	0.00197	CcSEcCtD
Indomethacin—Deafness—Docetaxel—skin cancer	0.000244	0.00195	CcSEcCtD
Indomethacin—Insomnia—Imiquimod—skin cancer	0.000243	0.00194	CcSEcCtD
Indomethacin—PTGS2—connective tissue—skin cancer	0.000242	0.00313	CbGeAlD
Indomethacin—Paraesthesia—Imiquimod—skin cancer	0.000241	0.00193	CcSEcCtD
Indomethacin—Cardiac failure congestive—Docetaxel—skin cancer	0.00024	0.00192	CcSEcCtD
Indomethacin—PTGS1—epithelium—skin cancer	0.00024	0.00311	CbGeAlD
Indomethacin—Dyspnoea—Imiquimod—skin cancer	0.00024	0.00191	CcSEcCtD
Indomethacin—Somnolence—Imiquimod—skin cancer	0.000239	0.00191	CcSEcCtD
Indomethacin—Alopecia—Bleomycin—skin cancer	0.000238	0.0019	CcSEcCtD
Indomethacin—Erythema multiforme—Dactinomycin—skin cancer	0.000237	0.00189	CcSEcCtD
Indomethacin—Dyspepsia—Imiquimod—skin cancer	0.000237	0.00189	CcSEcCtD
Indomethacin—Erythema—Bleomycin—skin cancer	0.000234	0.00187	CcSEcCtD
Indomethacin—Decreased appetite—Imiquimod—skin cancer	0.000234	0.00187	CcSEcCtD
Indomethacin—Hot flush—Docetaxel—skin cancer	0.000233	0.00186	CcSEcCtD
Indomethacin—Flushing—Dactinomycin—skin cancer	0.000233	0.00186	CcSEcCtD
Indomethacin—Hypersensitivity—Vemurafenib—skin cancer	0.000232	0.00185	CcSEcCtD
Indomethacin—Fatigue—Imiquimod—skin cancer	0.000232	0.00185	CcSEcCtD
Indomethacin—Menopausal symptoms—Docetaxel—skin cancer	0.000231	0.00184	CcSEcCtD
Indomethacin—Pain—Imiquimod—skin cancer	0.00023	0.00184	CcSEcCtD
Indomethacin—PTGS2—epithelium—skin cancer	0.000229	0.00297	CbGeAlD
Indomethacin—Renal impairment—Docetaxel—skin cancer	0.000229	0.00183	CcSEcCtD
Indomethacin—PTGS1—skin of body—skin cancer	0.000228	0.00295	CbGeAlD
Indomethacin—Neuropathy peripheral—Fluorouracil—skin cancer	0.000228	0.00182	CcSEcCtD
Indomethacin—Haemoglobin—Temozolomide—skin cancer	0.000228	0.00182	CcSEcCtD
Indomethacin—Stomatitis—Fluorouracil—skin cancer	0.000227	0.00181	CcSEcCtD
Indomethacin—Hepatitis—Temozolomide—skin cancer	0.000227	0.00181	CcSEcCtD
Indomethacin—Haemorrhage—Temozolomide—skin cancer	0.000227	0.00181	CcSEcCtD
Indomethacin—Asthenia—Vemurafenib—skin cancer	0.000226	0.00181	CcSEcCtD
Indomethacin—Pruritus—Vemurafenib—skin cancer	0.000223	0.00178	CcSEcCtD
Indomethacin—Alopecia—Dactinomycin—skin cancer	0.000222	0.00177	CcSEcCtD
Indomethacin—Feeling abnormal—Imiquimod—skin cancer	0.000222	0.00177	CcSEcCtD
Indomethacin—Gastrointestinal pain—Imiquimod—skin cancer	0.00022	0.00176	CcSEcCtD
Indomethacin—Epistaxis—Fluorouracil—skin cancer	0.000219	0.00175	CcSEcCtD
Indomethacin—Hyponatraemia—Docetaxel—skin cancer	0.000219	0.00175	CcSEcCtD
Indomethacin—PTGS2—skin of body—skin cancer	0.000218	0.00282	CbGeAlD
Indomethacin—Erythema—Dactinomycin—skin cancer	0.000218	0.00174	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000218	0.00174	CcSEcCtD
Indomethacin—Agranulocytosis—Fluorouracil—skin cancer	0.000217	0.00173	CcSEcCtD
Indomethacin—Ill-defined disorder—Bleomycin—skin cancer	0.000217	0.00173	CcSEcCtD
Indomethacin—Anaemia—Bleomycin—skin cancer	0.000216	0.00173	CcSEcCtD
Indomethacin—Diarrhoea—Vemurafenib—skin cancer	0.000216	0.00172	CcSEcCtD
Indomethacin—ABCC3—lymph node—skin cancer	0.000215	0.00278	CbGeAlD
Indomethacin—Erythema multiforme—Temozolomide—skin cancer	0.000214	0.00171	CcSEcCtD
Indomethacin—Urticaria—Imiquimod—skin cancer	0.000214	0.00171	CcSEcCtD
Indomethacin—Body temperature increased—Imiquimod—skin cancer	0.000212	0.0017	CcSEcCtD
Indomethacin—Abdominal pain—Imiquimod—skin cancer	0.000212	0.0017	CcSEcCtD
Indomethacin—Tinnitus—Temozolomide—skin cancer	0.000211	0.00169	CcSEcCtD
Indomethacin—Malaise—Bleomycin—skin cancer	0.000211	0.00169	CcSEcCtD
Indomethacin—Flushing—Temozolomide—skin cancer	0.00021	0.00168	CcSEcCtD
Indomethacin—Haemoglobin—Fluorouracil—skin cancer	0.00021	0.00168	CcSEcCtD
Indomethacin—Leukopenia—Bleomycin—skin cancer	0.000209	0.00167	CcSEcCtD
Indomethacin—Haemorrhage—Fluorouracil—skin cancer	0.000209	0.00167	CcSEcCtD
Indomethacin—Dizziness—Vemurafenib—skin cancer	0.000208	0.00166	CcSEcCtD
Indomethacin—PTGS1—mammalian vulva—skin cancer	0.000208	0.00269	CbGeAlD
Indomethacin—Ill-defined disorder—Dactinomycin—skin cancer	0.000202	0.00162	CcSEcCtD
Indomethacin—Anaemia—Dactinomycin—skin cancer	0.000202	0.00161	CcSEcCtD
Indomethacin—Vomiting—Vemurafenib—skin cancer	0.0002	0.0016	CcSEcCtD
Indomethacin—Alopecia—Temozolomide—skin cancer	0.0002	0.0016	CcSEcCtD
Indomethacin—Chest pain—Bleomycin—skin cancer	0.000199	0.00159	CcSEcCtD
Indomethacin—Abdominal pain upper—Docetaxel—skin cancer	0.000199	0.00159	CcSEcCtD
Indomethacin—Rash—Vemurafenib—skin cancer	0.000199	0.00159	CcSEcCtD
Indomethacin—Dermatitis—Vemurafenib—skin cancer	0.000199	0.00159	CcSEcCtD
Indomethacin—Hypersensitivity—Imiquimod—skin cancer	0.000198	0.00158	CcSEcCtD
Indomethacin—Headache—Vemurafenib—skin cancer	0.000197	0.00158	CcSEcCtD
Indomethacin—Erythema—Temozolomide—skin cancer	0.000197	0.00158	CcSEcCtD
Indomethacin—Discomfort—Bleomycin—skin cancer	0.000197	0.00157	CcSEcCtD
Indomethacin—Malaise—Dactinomycin—skin cancer	0.000197	0.00157	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000196	0.00157	CcSEcCtD
Indomethacin—CYP2C9—female reproductive system—skin cancer	0.000195	0.00253	CbGeAlD
Indomethacin—Leukopenia—Dactinomycin—skin cancer	0.000195	0.00156	CcSEcCtD
Indomethacin—PPARG—lymph node—skin cancer	0.000195	0.00253	CbGeAlD
Indomethacin—Asthenia—Imiquimod—skin cancer	0.000193	0.00154	CcSEcCtD
Indomethacin—Confusional state—Bleomycin—skin cancer	0.000193	0.00154	CcSEcCtD
Indomethacin—Oedema—Bleomycin—skin cancer	0.000191	0.00153	CcSEcCtD
Indomethacin—Anaphylactic shock—Bleomycin—skin cancer	0.000191	0.00153	CcSEcCtD
Indomethacin—Pruritus—Imiquimod—skin cancer	0.00019	0.00152	CcSEcCtD
Indomethacin—Nausea—Vemurafenib—skin cancer	0.000187	0.0015	CcSEcCtD
Indomethacin—Thrombocytopenia—Bleomycin—skin cancer	0.000187	0.00149	CcSEcCtD
Indomethacin—Arrhythmia—Fluorouracil—skin cancer	0.000187	0.00149	CcSEcCtD
Indomethacin—Vision blurred—Temozolomide—skin cancer	0.000186	0.00149	CcSEcCtD
Indomethacin—Alopecia—Fluorouracil—skin cancer	0.000185	0.00147	CcSEcCtD
Indomethacin—Diarrhoea—Imiquimod—skin cancer	0.000184	0.00147	CcSEcCtD
Indomethacin—Discomfort—Dactinomycin—skin cancer	0.000184	0.00147	CcSEcCtD
Indomethacin—Ill-defined disorder—Temozolomide—skin cancer	0.000183	0.00146	CcSEcCtD
Indomethacin—ALB—lymph node—skin cancer	0.000183	0.00237	CbGeAlD
Indomethacin—Anaemia—Temozolomide—skin cancer	0.000182	0.00146	CcSEcCtD
Indomethacin—Anorexia—Bleomycin—skin cancer	0.000182	0.00145	CcSEcCtD
Indomethacin—Erythema—Fluorouracil—skin cancer	0.000182	0.00145	CcSEcCtD
Indomethacin—Angioedema—Temozolomide—skin cancer	0.00018	0.00144	CcSEcCtD
Indomethacin—Pancytopenia—Docetaxel—skin cancer	0.000179	0.00143	CcSEcCtD
Indomethacin—Hypotension—Bleomycin—skin cancer	0.000178	0.00143	CcSEcCtD
Indomethacin—PTGS1—female reproductive system—skin cancer	0.000178	0.00231	CbGeAlD
Indomethacin—Oedema—Dactinomycin—skin cancer	0.000178	0.00142	CcSEcCtD
Indomethacin—Malaise—Temozolomide—skin cancer	0.000178	0.00142	CcSEcCtD
Indomethacin—Dizziness—Imiquimod—skin cancer	0.000178	0.00142	CcSEcCtD
Indomethacin—Vertigo—Temozolomide—skin cancer	0.000177	0.00142	CcSEcCtD
Indomethacin—ABCC4—lymph node—skin cancer	0.000177	0.00229	CbGeAlD
Indomethacin—PTGS2—lymphoid tissue—skin cancer	0.000177	0.00229	CbGeAlD
Indomethacin—Leukopenia—Temozolomide—skin cancer	0.000177	0.00141	CcSEcCtD
Indomethacin—Palpitations—Temozolomide—skin cancer	0.000174	0.00139	CcSEcCtD
Indomethacin—Thrombocytopenia—Dactinomycin—skin cancer	0.000174	0.00139	CcSEcCtD
Indomethacin—ABCC2—lymph node—skin cancer	0.000172	0.00222	CbGeAlD
Indomethacin—Paraesthesia—Bleomycin—skin cancer	0.000171	0.00137	CcSEcCtD
Indomethacin—Weight increased—Docetaxel—skin cancer	0.000171	0.00137	CcSEcCtD
Indomethacin—Vision blurred—Fluorouracil—skin cancer	0.000171	0.00137	CcSEcCtD
Indomethacin—Convulsion—Temozolomide—skin cancer	0.000171	0.00137	CcSEcCtD
Indomethacin—Vomiting—Imiquimod—skin cancer	0.000171	0.00137	CcSEcCtD
Indomethacin—PTGS2—female reproductive system—skin cancer	0.00017	0.00221	CbGeAlD
Indomethacin—Hypertension—Temozolomide—skin cancer	0.00017	0.00136	CcSEcCtD
Indomethacin—Dyspnoea—Bleomycin—skin cancer	0.00017	0.00136	CcSEcCtD
Indomethacin—Anorexia—Dactinomycin—skin cancer	0.00017	0.00136	CcSEcCtD
Indomethacin—Rash—Imiquimod—skin cancer	0.000169	0.00135	CcSEcCtD
Indomethacin—Dermatitis—Imiquimod—skin cancer	0.000169	0.00135	CcSEcCtD
Indomethacin—Headache—Imiquimod—skin cancer	0.000168	0.00134	CcSEcCtD
Indomethacin—Anaemia—Fluorouracil—skin cancer	0.000168	0.00134	CcSEcCtD
Indomethacin—Anxiety—Temozolomide—skin cancer	0.000167	0.00134	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000167	0.00133	CcSEcCtD
Indomethacin—Discomfort—Temozolomide—skin cancer	0.000166	0.00133	CcSEcCtD
Indomethacin—Decreased appetite—Bleomycin—skin cancer	0.000166	0.00133	CcSEcCtD
Indomethacin—Renal failure—Docetaxel—skin cancer	0.000165	0.00132	CcSEcCtD
Indomethacin—Neuropathy peripheral—Docetaxel—skin cancer	0.000165	0.00131	CcSEcCtD
Indomethacin—Jaundice—Docetaxel—skin cancer	0.000164	0.00131	CcSEcCtD
Indomethacin—Stomatitis—Docetaxel—skin cancer	0.000164	0.00131	CcSEcCtD
Indomethacin—Pain—Bleomycin—skin cancer	0.000163	0.0013	CcSEcCtD
Indomethacin—Leukopenia—Fluorouracil—skin cancer	0.000163	0.0013	CcSEcCtD
Indomethacin—Confusional state—Temozolomide—skin cancer	0.000162	0.0013	CcSEcCtD
Indomethacin—Oedema—Temozolomide—skin cancer	0.000161	0.00129	CcSEcCtD
Indomethacin—Anaphylactic shock—Temozolomide—skin cancer	0.000161	0.00129	CcSEcCtD
Indomethacin—Nausea—Imiquimod—skin cancer	0.00016	0.00128	CcSEcCtD
Indomethacin—Epistaxis—Docetaxel—skin cancer	0.000158	0.00127	CcSEcCtD
Indomethacin—Thrombocytopenia—Temozolomide—skin cancer	0.000158	0.00126	CcSEcCtD
Indomethacin—Convulsion—Fluorouracil—skin cancer	0.000158	0.00126	CcSEcCtD
Indomethacin—Feeling abnormal—Bleomycin—skin cancer	0.000157	0.00126	CcSEcCtD
Indomethacin—Agranulocytosis—Docetaxel—skin cancer	0.000157	0.00125	CcSEcCtD
Indomethacin—Hyperhidrosis—Temozolomide—skin cancer	0.000156	0.00124	CcSEcCtD
Indomethacin—Chest pain—Fluorouracil—skin cancer	0.000155	0.00124	CcSEcCtD
Indomethacin—Decreased appetite—Dactinomycin—skin cancer	0.000155	0.00124	CcSEcCtD
Indomethacin—Fatigue—Dactinomycin—skin cancer	0.000154	0.00123	CcSEcCtD
Indomethacin—Anorexia—Temozolomide—skin cancer	0.000154	0.00123	CcSEcCtD
Indomethacin—Discomfort—Fluorouracil—skin cancer	0.000153	0.00122	CcSEcCtD
Indomethacin—Pain—Dactinomycin—skin cancer	0.000152	0.00122	CcSEcCtD
Indomethacin—Urticaria—Bleomycin—skin cancer	0.000152	0.00121	CcSEcCtD
Indomethacin—Haemoglobin—Docetaxel—skin cancer	0.000152	0.00121	CcSEcCtD
Indomethacin—ABCC1—lymph node—skin cancer	0.000151	0.00196	CbGeAlD
Indomethacin—Body temperature increased—Bleomycin—skin cancer	0.000151	0.00121	CcSEcCtD
Indomethacin—Hepatitis—Docetaxel—skin cancer	0.000151	0.0012	CcSEcCtD
Indomethacin—Haemorrhage—Docetaxel—skin cancer	0.000151	0.0012	CcSEcCtD
Indomethacin—Confusional state—Fluorouracil—skin cancer	0.00015	0.0012	CcSEcCtD
Indomethacin—PTGS1—head—skin cancer	0.000149	0.00193	CbGeAlD
Indomethacin—Anaphylactic shock—Fluorouracil—skin cancer	0.000148	0.00119	CcSEcCtD
Indomethacin—Oedema—Fluorouracil—skin cancer	0.000148	0.00119	CcSEcCtD
Indomethacin—Feeling abnormal—Dactinomycin—skin cancer	0.000147	0.00117	CcSEcCtD
Indomethacin—Insomnia—Temozolomide—skin cancer	0.000146	0.00116	CcSEcCtD
Indomethacin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000146	0.00116	CcSEcCtD
Indomethacin—Thrombocytopenia—Fluorouracil—skin cancer	0.000145	0.00116	CcSEcCtD
Indomethacin—Tachycardia—Fluorouracil—skin cancer	0.000145	0.00116	CcSEcCtD
Indomethacin—Paraesthesia—Temozolomide—skin cancer	0.000145	0.00116	CcSEcCtD
Indomethacin—Dyspnoea—Temozolomide—skin cancer	0.000144	0.00115	CcSEcCtD
Indomethacin—Somnolence—Temozolomide—skin cancer	0.000143	0.00114	CcSEcCtD
Indomethacin—Erythema multiforme—Docetaxel—skin cancer	0.000143	0.00114	CcSEcCtD
Indomethacin—PTGS2—head—skin cancer	0.000142	0.00184	CbGeAlD
Indomethacin—ABCB1—epithelium—skin cancer	0.000142	0.00184	CbGeAlD
Indomethacin—Dyspepsia—Temozolomide—skin cancer	0.000142	0.00113	CcSEcCtD
Indomethacin—Anorexia—Fluorouracil—skin cancer	0.000141	0.00113	CcSEcCtD
Indomethacin—Abdominal pain—Dactinomycin—skin cancer	0.000141	0.00112	CcSEcCtD
Indomethacin—Body temperature increased—Dactinomycin—skin cancer	0.000141	0.00112	CcSEcCtD
Indomethacin—Hypersensitivity—Bleomycin—skin cancer	0.000141	0.00112	CcSEcCtD
Indomethacin—Decreased appetite—Temozolomide—skin cancer	0.00014	0.00112	CcSEcCtD
Indomethacin—Flushing—Docetaxel—skin cancer	0.00014	0.00112	CcSEcCtD
Indomethacin—Fatigue—Temozolomide—skin cancer	0.000139	0.00111	CcSEcCtD
Indomethacin—Hypotension—Fluorouracil—skin cancer	0.000139	0.00111	CcSEcCtD
Indomethacin—Pain—Temozolomide—skin cancer	0.000138	0.0011	CcSEcCtD
Indomethacin—Constipation—Temozolomide—skin cancer	0.000138	0.0011	CcSEcCtD
Indomethacin—Asthenia—Bleomycin—skin cancer	0.000137	0.00109	CcSEcCtD
Indomethacin—Pruritus—Bleomycin—skin cancer	0.000135	0.00108	CcSEcCtD
Indomethacin—Arrhythmia—Docetaxel—skin cancer	0.000135	0.00108	CcSEcCtD
Indomethacin—Insomnia—Fluorouracil—skin cancer	0.000134	0.00107	CcSEcCtD
Indomethacin—Paraesthesia—Fluorouracil—skin cancer	0.000133	0.00106	CcSEcCtD
Indomethacin—Alopecia—Docetaxel—skin cancer	0.000133	0.00106	CcSEcCtD
Indomethacin—Feeling abnormal—Temozolomide—skin cancer	0.000133	0.00106	CcSEcCtD
Indomethacin—Dyspnoea—Fluorouracil—skin cancer	0.000132	0.00106	CcSEcCtD
Indomethacin—Somnolence—Fluorouracil—skin cancer	0.000132	0.00105	CcSEcCtD
Indomethacin—Gastrointestinal pain—Temozolomide—skin cancer	0.000132	0.00105	CcSEcCtD
Indomethacin—Erythema—Docetaxel—skin cancer	0.000131	0.00105	CcSEcCtD
Indomethacin—Hypersensitivity—Dactinomycin—skin cancer	0.000131	0.00105	CcSEcCtD
Indomethacin—Dyspepsia—Fluorouracil—skin cancer	0.000131	0.00104	CcSEcCtD
Indomethacin—Decreased appetite—Fluorouracil—skin cancer	0.000129	0.00103	CcSEcCtD
Indomethacin—Urticaria—Temozolomide—skin cancer	0.000128	0.00102	CcSEcCtD
Indomethacin—Asthenia—Dactinomycin—skin cancer	0.000128	0.00102	CcSEcCtD
Indomethacin—Abdominal pain—Temozolomide—skin cancer	0.000127	0.00102	CcSEcCtD
Indomethacin—Body temperature increased—Temozolomide—skin cancer	0.000127	0.00102	CcSEcCtD
Indomethacin—Pain—Fluorouracil—skin cancer	0.000127	0.00101	CcSEcCtD
Indomethacin—ABCB1—mammalian vulva—skin cancer	0.000123	0.00159	CbGeAlD
Indomethacin—Feeling abnormal—Fluorouracil—skin cancer	0.000122	0.000977	CcSEcCtD
Indomethacin—Diarrhoea—Dactinomycin—skin cancer	0.000122	0.000973	CcSEcCtD
Indomethacin—Vomiting—Bleomycin—skin cancer	0.000121	0.00097	CcSEcCtD
Indomethacin—Anaemia—Docetaxel—skin cancer	0.000121	0.000969	CcSEcCtD
Indomethacin—Rash—Bleomycin—skin cancer	0.00012	0.000962	CcSEcCtD
Indomethacin—Dermatitis—Bleomycin—skin cancer	0.00012	0.000961	CcSEcCtD
Indomethacin—Hypersensitivity—Temozolomide—skin cancer	0.000119	0.000948	CcSEcCtD
Indomethacin—Urticaria—Fluorouracil—skin cancer	0.000118	0.000942	CcSEcCtD
Indomethacin—Syncope—Docetaxel—skin cancer	0.000118	0.00094	CcSEcCtD
Indomethacin—Leukopenia—Docetaxel—skin cancer	0.000117	0.000938	CcSEcCtD
Indomethacin—Body temperature increased—Fluorouracil—skin cancer	0.000117	0.000937	CcSEcCtD
Indomethacin—Palpitations—Docetaxel—skin cancer	0.000116	0.000926	CcSEcCtD
Indomethacin—Asthenia—Temozolomide—skin cancer	0.000116	0.000923	CcSEcCtD
Indomethacin—Loss of consciousness—Docetaxel—skin cancer	0.000115	0.000921	CcSEcCtD
Indomethacin—Pruritus—Temozolomide—skin cancer	0.000114	0.00091	CcSEcCtD
Indomethacin—Convulsion—Docetaxel—skin cancer	0.000114	0.000908	CcSEcCtD
Indomethacin—Nausea—Bleomycin—skin cancer	0.000113	0.000906	CcSEcCtD
Indomethacin—Hypertension—Docetaxel—skin cancer	0.000113	0.000905	CcSEcCtD
Indomethacin—Vomiting—Dactinomycin—skin cancer	0.000113	0.000904	CcSEcCtD
Indomethacin—Rash—Dactinomycin—skin cancer	0.000112	0.000897	CcSEcCtD
Indomethacin—Chest pain—Docetaxel—skin cancer	0.000112	0.000893	CcSEcCtD
Indomethacin—Diarrhoea—Temozolomide—skin cancer	0.00011	0.00088	CcSEcCtD
Indomethacin—Hypersensitivity—Fluorouracil—skin cancer	0.000109	0.000873	CcSEcCtD
Indomethacin—ABCB1—lymphoid tissue—skin cancer	0.000109	0.00141	CbGeAlD
Indomethacin—Confusional state—Docetaxel—skin cancer	0.000108	0.000863	CcSEcCtD
Indomethacin—Oedema—Docetaxel—skin cancer	0.000107	0.000856	CcSEcCtD
Indomethacin—Anaphylactic shock—Docetaxel—skin cancer	0.000107	0.000856	CcSEcCtD
Indomethacin—Dizziness—Temozolomide—skin cancer	0.000107	0.000851	CcSEcCtD
Indomethacin—Nausea—Dactinomycin—skin cancer	0.000106	0.000845	CcSEcCtD
Indomethacin—ABCB1—female reproductive system—skin cancer	0.000105	0.00136	CbGeAlD
Indomethacin—Shock—Docetaxel—skin cancer	0.000105	0.000842	CcSEcCtD
Indomethacin—Pruritus—Fluorouracil—skin cancer	0.000105	0.000839	CcSEcCtD
Indomethacin—Thrombocytopenia—Docetaxel—skin cancer	0.000105	0.000838	CcSEcCtD
Indomethacin—Tachycardia—Docetaxel—skin cancer	0.000105	0.000835	CcSEcCtD
Indomethacin—PTGS1—lymph node—skin cancer	0.000104	0.00135	CbGeAlD
Indomethacin—Vomiting—Temozolomide—skin cancer	0.000102	0.000818	CcSEcCtD
Indomethacin—Anorexia—Docetaxel—skin cancer	0.000102	0.000816	CcSEcCtD
Indomethacin—Rash—Temozolomide—skin cancer	0.000102	0.000811	CcSEcCtD
Indomethacin—Diarrhoea—Fluorouracil—skin cancer	0.000102	0.000811	CcSEcCtD
Indomethacin—Dermatitis—Temozolomide—skin cancer	0.000101	0.00081	CcSEcCtD
Indomethacin—Headache—Temozolomide—skin cancer	0.000101	0.000806	CcSEcCtD
Indomethacin—Hypotension—Docetaxel—skin cancer	0.0001	0.000799	CcSEcCtD
Indomethacin—PTGS2—lymph node—skin cancer	9.97e-05	0.00129	CbGeAlD
Indomethacin—Dizziness—Fluorouracil—skin cancer	9.81e-05	0.000784	CcSEcCtD
Indomethacin—Insomnia—Docetaxel—skin cancer	9.69e-05	0.000774	CcSEcCtD
Indomethacin—Paraesthesia—Docetaxel—skin cancer	9.62e-05	0.000768	CcSEcCtD
Indomethacin—Nausea—Temozolomide—skin cancer	9.57e-05	0.000764	CcSEcCtD
Indomethacin—Dyspnoea—Docetaxel—skin cancer	9.55e-05	0.000763	CcSEcCtD
Indomethacin—Somnolence—Docetaxel—skin cancer	9.52e-05	0.000761	CcSEcCtD
Indomethacin—Vomiting—Fluorouracil—skin cancer	9.44e-05	0.000754	CcSEcCtD
Indomethacin—Dyspepsia—Docetaxel—skin cancer	9.43e-05	0.000753	CcSEcCtD
Indomethacin—Rash—Fluorouracil—skin cancer	9.36e-05	0.000747	CcSEcCtD
Indomethacin—Dermatitis—Fluorouracil—skin cancer	9.35e-05	0.000747	CcSEcCtD
Indomethacin—Decreased appetite—Docetaxel—skin cancer	9.31e-05	0.000744	CcSEcCtD
Indomethacin—Headache—Fluorouracil—skin cancer	9.3e-05	0.000743	CcSEcCtD
Indomethacin—Fatigue—Docetaxel—skin cancer	9.24e-05	0.000738	CcSEcCtD
Indomethacin—Pain—Docetaxel—skin cancer	9.16e-05	0.000732	CcSEcCtD
Indomethacin—Constipation—Docetaxel—skin cancer	9.16e-05	0.000732	CcSEcCtD
Indomethacin—Feeling abnormal—Docetaxel—skin cancer	8.83e-05	0.000705	CcSEcCtD
Indomethacin—Nausea—Fluorouracil—skin cancer	8.82e-05	0.000704	CcSEcCtD
Indomethacin—ABCB1—head—skin cancer	8.81e-05	0.00114	CbGeAlD
Indomethacin—Gastrointestinal pain—Docetaxel—skin cancer	8.76e-05	0.0007	CcSEcCtD
Indomethacin—Body temperature increased—Docetaxel—skin cancer	8.47e-05	0.000676	CcSEcCtD
Indomethacin—Abdominal pain—Docetaxel—skin cancer	8.47e-05	0.000676	CcSEcCtD
Indomethacin—Hypersensitivity—Docetaxel—skin cancer	7.89e-05	0.00063	CcSEcCtD
Indomethacin—Asthenia—Docetaxel—skin cancer	7.69e-05	0.000614	CcSEcCtD
Indomethacin—Pruritus—Docetaxel—skin cancer	7.58e-05	0.000605	CcSEcCtD
Indomethacin—Diarrhoea—Docetaxel—skin cancer	7.33e-05	0.000585	CcSEcCtD
Indomethacin—Dizziness—Docetaxel—skin cancer	7.08e-05	0.000566	CcSEcCtD
Indomethacin—Vomiting—Docetaxel—skin cancer	6.81e-05	0.000544	CcSEcCtD
Indomethacin—Rash—Docetaxel—skin cancer	6.75e-05	0.000539	CcSEcCtD
Indomethacin—Dermatitis—Docetaxel—skin cancer	6.75e-05	0.000539	CcSEcCtD
Indomethacin—Headache—Docetaxel—skin cancer	6.71e-05	0.000536	CcSEcCtD
Indomethacin—Nausea—Docetaxel—skin cancer	6.36e-05	0.000508	CcSEcCtD
Indomethacin—ABCB1—lymph node—skin cancer	6.17e-05	0.000798	CbGeAlD
Indomethacin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—skin cancer	4.53e-05	0.0009	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	4.49e-05	0.000892	CbGpPWpGaD
Indomethacin—CXCL8—Senescence and Autophagy in Cancer—IL6—skin cancer	4.43e-05	0.00088	CbGpPWpGaD
Indomethacin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—skin cancer	4.43e-05	0.00088	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—TP53—skin cancer	4.41e-05	0.000875	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTCH2—skin cancer	4.36e-05	0.000867	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—CSPG4—skin cancer	4.35e-05	0.000864	CbGpPWpGaD
Indomethacin—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	4.27e-05	0.000848	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	4.26e-05	0.000846	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—GLI2—skin cancer	4.19e-05	0.000833	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—CDKN2A—skin cancer	4.16e-05	0.000826	CbGpPWpGaD
Indomethacin—PPARA—Adipogenesis—IL6—skin cancer	4.1e-05	0.000815	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PLIN2—skin cancer	4.09e-05	0.000812	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PLIN2—skin cancer	4.09e-05	0.000812	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—SHH—skin cancer	4.07e-05	0.000809	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—ENO2—skin cancer	4.07e-05	0.000809	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—IL6—skin cancer	4.03e-05	0.000801	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MC1R—skin cancer	4e-05	0.000795	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—ENO2—skin cancer	3.96e-05	0.000788	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—GLI1—skin cancer	3.94e-05	0.000783	CbGpPWpGaD
Indomethacin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	3.92e-05	0.000779	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.9e-05	0.000776	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—PTGER4—skin cancer	3.87e-05	0.000768	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PLIN2—skin cancer	3.87e-05	0.000768	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—SHH—skin cancer	3.81e-05	0.000756	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SUFU—skin cancer	3.74e-05	0.000743	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.65e-05	0.000724	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—CDK4—skin cancer	3.62e-05	0.000719	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—SMO—skin cancer	3.61e-05	0.000717	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PTCH1—skin cancer	3.61e-05	0.000717	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PLIN2—skin cancer	3.56e-05	0.000707	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	3.54e-05	0.000703	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.52e-05	0.000699	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PTGER4—skin cancer	3.51e-05	0.000698	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.51e-05	0.000696	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ENO2—skin cancer	3.41e-05	0.000677	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PLIN2—skin cancer	3.32e-05	0.00066	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PLIN2—skin cancer	3.32e-05	0.00066	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—FOXO4—skin cancer	3.32e-05	0.000659	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	3.32e-05	0.000659	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—NRAS—skin cancer	3.31e-05	0.000658	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—GLI2—skin cancer	3.31e-05	0.000657	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CSPG4—skin cancer	3.29e-05	0.000655	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CSPG4—skin cancer	3.29e-05	0.000655	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—IL6—skin cancer	3.23e-05	0.000641	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PLIN2—skin cancer	3.2e-05	0.000636	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.2e-05	0.000635	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—TP53—skin cancer	3.16e-05	0.000628	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MC1R—skin cancer	3.16e-05	0.000627	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TERT—skin cancer	3.14e-05	0.000624	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CSPG4—skin cancer	3.12e-05	0.000619	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—GLI1—skin cancer	3.11e-05	0.000618	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.1e-05	0.000616	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	3.09e-05	0.000613	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.08e-05	0.000613	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CSPG4—skin cancer	3.08e-05	0.000613	CbGpPWpGaD
Indomethacin—CXCL8—Cellular Senescence—TP53—skin cancer	3.06e-05	0.000608	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PLIN2—skin cancer	3.04e-05	0.000605	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ENO2—skin cancer	2.96e-05	0.000587	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SUFU—skin cancer	2.95e-05	0.000586	CbGpPWpGaD
Indomethacin—PPARG—Adipogenesis—IL6—skin cancer	2.94e-05	0.000584	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—IL6—skin cancer	2.89e-05	0.000575	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CSPG4—skin cancer	2.87e-05	0.00057	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SHH—skin cancer	2.85e-05	0.000566	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	2.85e-05	0.000566	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RASA1—skin cancer	2.83e-05	0.000563	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	2.81e-05	0.000559	CbGpPWpGaD
Indomethacin—CXCL8—Cellular Senescence—IL6—skin cancer	2.8e-05	0.000557	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—IL6—skin cancer	2.8e-05	0.000556	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—ERCC2—skin cancer	2.71e-05	0.000538	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PLIN2—skin cancer	2.71e-05	0.000538	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SMO—skin cancer	2.7e-05	0.000537	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTCH1—skin cancer	2.7e-05	0.000537	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CSPG4—skin cancer	2.68e-05	0.000532	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CSPG4—skin cancer	2.68e-05	0.000532	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.67e-05	0.00053	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—NRAS—skin cancer	2.65e-05	0.000526	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTGER4—skin cancer	2.63e-05	0.000523	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—CDK4—skin cancer	2.59e-05	0.000516	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CSPG4—skin cancer	2.58e-05	0.000513	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—BRAF—skin cancer	2.49e-05	0.000494	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TP53—skin cancer	2.49e-05	0.000494	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CSPG4—skin cancer	2.45e-05	0.000487	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	2.42e-05	0.000481	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—ERCC2—skin cancer	2.36e-05	0.00047	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—FOXO4—skin cancer	2.32e-05	0.000462	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—TP53—skin cancer	2.31e-05	0.00046	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.31e-05	0.000459	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—ERCC2—skin cancer	2.3e-05	0.000457	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—KRAS—skin cancer	2.28e-05	0.000453	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—IL6—skin cancer	2.27e-05	0.000452	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—TP53—skin cancer	2.27e-05	0.00045	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SHH—skin cancer	2.25e-05	0.000447	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ENO2—skin cancer	2.24e-05	0.000445	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ENO2—skin cancer	2.24e-05	0.000445	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RASA1—skin cancer	2.23e-05	0.000444	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	2.23e-05	0.000444	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TERT—skin cancer	2.22e-05	0.00044	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—ERCC2—skin cancer	2.21e-05	0.000439	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.19e-05	0.000435	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CSPG4—skin cancer	2.18e-05	0.000434	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PLIN2—skin cancer	2.15e-05	0.000427	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTCH1—skin cancer	2.13e-05	0.000423	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SMO—skin cancer	2.13e-05	0.000423	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ENO2—skin cancer	2.12e-05	0.000421	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—IL6—skin cancer	2.12e-05	0.000421	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SHH—skin cancer	2.1e-05	0.000416	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ENO2—skin cancer	2.1e-05	0.000416	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTGER4—skin cancer	2.07e-05	0.000412	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—IL6—skin cancer	2.07e-05	0.000412	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CSPG4—skin cancer	2.07e-05	0.000411	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—NRAS—skin cancer	2.01e-05	0.0004	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ERCC2—skin cancer	1.98e-05	0.000393	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ENO2—skin cancer	1.95e-05	0.000387	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—HRAS—skin cancer	1.94e-05	0.000385	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TP53—skin cancer	1.93e-05	0.000383	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—IL6—skin cancer	1.85e-05	0.000368	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—FOXO4—skin cancer	1.83e-05	0.000364	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ENO2—skin cancer	1.82e-05	0.000362	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ENO2—skin cancer	1.82e-05	0.000362	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—IL6—skin cancer	1.81e-05	0.000359	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IL6—skin cancer	1.77e-05	0.000351	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—BRAF—skin cancer	1.75e-05	0.000349	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ENO2—skin cancer	1.75e-05	0.000349	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.75e-05	0.000348	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLIN2—skin cancer	1.74e-05	0.000346	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—KRAS—skin cancer	1.73e-05	0.000344	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CSPG4—skin cancer	1.73e-05	0.000344	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ERCC2—skin cancer	1.72e-05	0.000341	CbGpPWpGaD
Indomethacin—ABCC1—Disease—FOXO4—skin cancer	1.71e-05	0.000339	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ENO2—skin cancer	1.67e-05	0.000331	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.66e-05	0.000329	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PTGS2—skin cancer	1.62e-05	0.000323	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—ERCC2—skin cancer	1.58e-05	0.000314	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NRAS—skin cancer	1.56e-05	0.000311	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.56e-05	0.000311	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLIN2—skin cancer	1.56e-05	0.00031	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TERT—skin cancer	1.55e-05	0.000308	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.53e-05	0.000303	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLIN2—skin cancer	1.52e-05	0.000303	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ENO2—skin cancer	1.48e-05	0.000295	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.48e-05	0.000293	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—HRAS—skin cancer	1.47e-05	0.000293	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—NRAS—skin cancer	1.44e-05	0.000287	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLIN2—skin cancer	1.42e-05	0.000283	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.42e-05	0.000283	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTGS2—skin cancer	1.42e-05	0.000282	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—IL6—skin cancer	1.41e-05	0.00028	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—NRAS—skin cancer	1.41e-05	0.00028	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SHH—skin cancer	1.41e-05	0.000279	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ENO2—skin cancer	1.41e-05	0.000279	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CSPG4—skin cancer	1.4e-05	0.000279	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTGS2—skin cancer	1.38e-05	0.000274	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.37e-05	0.000273	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—KRAS—skin cancer	1.35e-05	0.000267	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.31e-05	0.000261	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.3e-05	0.000259	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ERCC2—skin cancer	1.3e-05	0.000258	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ERCC2—skin cancer	1.3e-05	0.000258	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CSPG4—skin cancer	1.26e-05	0.00025	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—KRAS—skin cancer	1.24e-05	0.000247	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ERCC2—skin cancer	1.23e-05	0.000244	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—BRAF—skin cancer	1.23e-05	0.000244	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CSPG4—skin cancer	1.23e-05	0.000244	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TERT—skin cancer	1.22e-05	0.000243	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERCC2—skin cancer	1.22e-05	0.000242	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—KRAS—skin cancer	1.21e-05	0.000241	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—skin cancer	1.2e-05	0.000238	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTGS2—skin cancer	1.19e-05	0.000236	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ENO2—skin cancer	1.18e-05	0.000234	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.16e-05	0.000231	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CSPG4—skin cancer	1.15e-05	0.000228	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FOXO4—skin cancer	1.15e-05	0.000228	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HRAS—skin cancer	1.14e-05	0.000227	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TERT—skin cancer	1.14e-05	0.000227	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ERCC2—skin cancer	1.13e-05	0.000225	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NRAS—skin cancer	1.1e-05	0.000219	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL6—skin cancer	1.09e-05	0.000218	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—skin cancer	1.08e-05	0.000214	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ERCC2—skin cancer	1.06e-05	0.00021	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ERCC2—skin cancer	1.06e-05	0.00021	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—HRAS—skin cancer	1.06e-05	0.00021	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.05e-05	0.000208	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—NRAS—skin cancer	1.03e-05	0.000205	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—HRAS—skin cancer	1.03e-05	0.000205	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—skin cancer	1.03e-05	0.000205	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ERCC2—skin cancer	1.02e-05	0.000203	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—IL6—skin cancer	1.01e-05	0.000201	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—BRAF—skin cancer	9.69e-06	0.000193	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ERCC2—skin cancer	9.69e-06	0.000192	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ENO2—skin cancer	9.53e-06	0.000189	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KRAS—skin cancer	9.49e-06	0.000189	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	9.31e-06	0.000185	CbGpPWpGaD
Indomethacin—ABCC1—Disease—BRAF—skin cancer	9.04e-06	0.00018	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—KRAS—skin cancer	8.88e-06	0.000176	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ERCC2—skin cancer	8.62e-06	0.000171	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ENO2—skin cancer	8.55e-06	0.00017	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ENO2—skin cancer	8.35e-06	0.000166	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERCC2—skin cancer	8.17e-06	0.000162	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—skin cancer	8.07e-06	0.00016	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—skin cancer	7.8e-06	0.000155	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—skin cancer	7.8e-06	0.000155	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ENO2—skin cancer	7.8e-06	0.000155	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRAS—skin cancer	7.72e-06	0.000153	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—skin cancer	7.72e-06	0.000153	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TERT—skin cancer	7.66e-06	0.000152	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—skin cancer	7.54e-06	0.00015	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.45e-06	0.000148	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—skin cancer	7.38e-06	0.000147	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—skin cancer	7.3e-06	0.000145	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—skin cancer	7.22e-06	0.000143	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ERCC2—skin cancer	6.84e-06	0.000136	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—skin cancer	6.79e-06	0.000135	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.69e-06	0.000133	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—skin cancer	6.65e-06	0.000132	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—skin cancer	6.37e-06	0.000127	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—skin cancer	6.34e-06	0.000126	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—skin cancer	6.34e-06	0.000126	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—skin cancer	6.11e-06	0.000121	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.1e-06	0.000121	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—skin cancer	6.09e-06	0.000121	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—skin cancer	6.06e-06	0.00012	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—skin cancer	5.91e-06	0.000117	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—skin cancer	5.81e-06	0.000115	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—skin cancer	5.68e-06	0.000113	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—skin cancer	5.65e-06	0.000112	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ERCC2—skin cancer	5.53e-06	0.00011	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—skin cancer	5.48e-06	0.000109	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—skin cancer	5.41e-06	0.000107	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—skin cancer	5.24e-06	0.000104	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—skin cancer	5.17e-06	0.000103	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ERCC2—skin cancer	4.97e-06	9.87e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—skin cancer	4.89e-06	9.71e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—skin cancer	4.87e-06	9.68e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ERCC2—skin cancer	4.85e-06	9.64e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—skin cancer	4.66e-06	9.26e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—skin cancer	4.66e-06	9.26e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ERCC2—skin cancer	4.53e-06	9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—skin cancer	4.46e-06	8.86e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—skin cancer	4.27e-06	8.48e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—skin cancer	4.15e-06	8.25e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—skin cancer	3.98e-06	7.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—skin cancer	3.81e-06	7.57e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—skin cancer	3.32e-06	6.59e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—skin cancer	3.28e-06	6.52e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—skin cancer	2.98e-06	5.92e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—skin cancer	2.91e-06	5.78e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—skin cancer	2.79e-06	5.54e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—skin cancer	2.72e-06	5.4e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—skin cancer	2.67e-06	5.3e-05	CbGpPWpGaD
